ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
2019 · Annals of Oncology · 1,101 citations
https://doi.org/10.1093/annonc/mdz062
M
Mansoor Raza Mirza
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
477
Papers
20.6K
Citations
58
h-index
149
i10-index
Mansoor Raza Mirza is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Endometrial and Cervical Cancer Treatments. The author has an h-index of 58, co-authored 406 publications.
ORCID: 0000-0002-8085-1010Papers by this author
worksStandard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
2015 · The Lancet Oncology · 845 citations
https://doi.org/10.1016/s1470-2045(15)00086-8
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
2015 · International Journal of Gynecological Cancer · 745 citations
https://doi.org/10.1097/igc.0000000000000609
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
2023 · New England Journal of Medicine · 718 citations
https://doi.org/10.1056/nejmoa2216334
ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
2015 · Radiotherapy and Oncology · 184 citations
https://doi.org/10.1016/j.radonc.2015.11.013
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
2021 · Annals of Oncology · 152 citations
https://doi.org/10.1016/j.annonc.2021.11.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat